MYC and Miyoshi myopathy: Interestingly, treatment with lenalidomide led to miR-22 upregulation only in U266 MYC cells, thus suggesting a pivotal role exerted by MYC in mediating miR-22 expression in MM cells upon lenalidomide treatment (Figure S4a).